Simpenan pasar, bursa saham saiki
Kuotasi saham saka 71229 perusahaan ing wektu nyata.
Simpenan pasar, bursa saham saiki

Saham kuotasi

Saham kuotasi online

Stock quotes history

Kapitalisasi pasar saham

Simpenan Dividen

Keuntungan saka saham perusahaan

Laporan keuangan

Rating saham perusahaan. Endi kanggo nandur modal dhuwit?

EyeGate Pharmaceuticals, Inc. tutup pasar

Volume perdagangan saham EyeGate Pharmaceuticals, Inc. saiki lan sajarah kapitalisasi EyeGate Pharmaceuticals, Inc. wiwit wiwitan dagang ing saham EYEG ing bursa saham.
Tambah menyang widget
Ditambahake karo widget

EyeGate Pharmaceuticals, Inc. kapitalisasi

Kapitalisasi pasar EyeGate Pharmaceuticals, Inc. saiki 24 673 546 Dolar Amérikah Sarékat.

EyeGate Pharmaceuticals, Inc. kapitalisasi kanthi online saiki dolar. EyeGate Pharmaceuticals, Inc. minangka jumlah kabeh EyeGate Pharmaceuticals, Inc. kuotasi saham sing ditanggepi. Sampeyan bisa ngerteni kapitalisasi EyeGate Pharmaceuticals, Inc. kanggo dina iki adhedhasar perdagangan kuotasi saham iki ing pasar bursa saham. EyeGate Pharmaceuticals, Inc., kapitalisasi - 24 673 546 dolar AS.

EyeGate Pharmaceuticals, Inc. volume perdagangan

Dina iki volume perdagangan saham EyeGate Pharmaceuticals, Inc. berjumlah 319 498 Dolar Amérikah Sarékat.
-149 041 $ (-31.81%)
owahan volume perdagangan wiwit wingi

EyeGate Pharmaceuticals, Inc. volume dagang saiki = 319 498 dolar AS. Bagan saben dina saka kelas dagang EyeGate Pharmaceuticals, Inc. wis ditampilake ing situs web kita. EyeGate Pharmaceuticals, Inc. dagang nyedhiyakake akeh bursa kuotasi saham ing wektu nyata, kita nuduhake volume dagang saben dina EyeGate Pharmaceuticals, Inc.. EyeGate Pharmaceuticals, Inc. kapitalisasi wis tambah $ 0.

Tampilake:
Kanggo

Bagan pasar EyeGate Pharmaceuticals, Inc.

EyeGate Pharmaceuticals, Inc. kapitalisasi ing grafik kanthi pirang-pirang taun. 0% saben wulan - pangowahan kapitalisasi pasar EyeGate Pharmaceuticals, Inc.. Swara taun, EyeGate Pharmaceuticals, Inc. kapital wis ganti dening 0%. Dina iki, EyeGate Pharmaceuticals, Inc. kapitalisasi diakoni ing 24 673 546 dolar AS

Minggu Wulan 3 months Taun 3 taun

Sajarah kapitalisasi EyeGate Pharmaceuticals, Inc.

Tanggal Kapitalisasi
Kapitalisasi (kapitalisasi pasar) iku nilai pasar kabeh saham perusahaan sing didol ing bursa saham. Kapitalisasi pasar sama dengan harga saham yang dikalikan dengan jumlah saham yang beredar.
05/11/2021 24 673 546 $
04/11/2021 24 673 546 $
03/11/2021 24 725 422 $
02/11/2021 24 860 022 $
01/11/2021 25 112 408 $
29/10/2021 24 548 402 $
28/10/2021 24 106 648 $

EyeGate Pharmaceuticals, Inc. volume chart

Minggu Wulan 3 months Taun 3 taun

EyeGate Pharmaceuticals, Inc. data riwayat volume

Tanggal Volume (24h)
Volume perdagangan saham EyeGate Pharmaceuticals, Inc. yaiku jumlah total kabeh transaksi karo saham EYEG sing dituku lan didol nalika tanggal sing dipilih.
05/11/2021 319 498 $
04/11/2021 468 539 $
03/11/2021 406 475 $
02/11/2021 30 050 $
01/11/2021 352 870 $
29/10/2021 319 427 $
28/10/2021 232 036 $

EyeGate Pharmaceuticals, Inc. kapitalisasi padha karo 24 673 546 dolar AS ing 05/11/2021. Ing 04/11/2021, EyeGate Pharmaceuticals, Inc. kapitalisasi pasar yaiku $ 24 673 546. EyeGate Pharmaceuticals, Inc. kapitalisasi pasar ing 03/11/2021 padha karo 24 725 422 dolar AS. EyeGate Pharmaceuticals, Inc. kapitalisasi cacahe 24 860 022 dolar AS ing 02/11/2021.

EyeGate Pharmaceuticals, Inc. kapitalisasi ing 01/11/2021 padha karo 25 112 408 dolar AS. EyeGate Pharmaceuticals, Inc. kapitalisasi pasar yaiku $ 24 548 402 ing 29/10/2021. EyeGate Pharmaceuticals, Inc. kapitalisasi ing 28/10/2021 cacahe 24 106 648 dolar AS.

Kapitalisasi EyeGate Pharmaceuticals, Inc. saat ini adalah 24 673 546 $. Kapitalisasi pasar EyeGate Pharmaceuticals, Inc. telah berubah menjadi 0% dibandhingake karo wingi. Volume perdagangan saham EYEG saka EyeGate Pharmaceuticals, Inc. ing dinten pungkasan pungkasan yaiku 319 498 $. Volume dagang saham EyeGate Pharmaceuticals, Inc. diganti dadi -31.81% yen dibandhingake dina dagang sadurunge.

Biaya saham EyeGate Pharmaceuticals, Inc.

Keuangan EyeGate Pharmaceuticals, Inc.